Cost-Effectiveness of Olanzapine as First-Line Treatment for Schizophrenia: Results from a Randomized, Open-Label, 1-Year Trial

✍ Scribed by Sandra L. Tunis; Douglas E. Faries; Allen W. Nyhuis; Bruce J. Kinon; Haya Ascher-Svanum; Ralph Aquila

• Book ID: 109078548
• Publisher: John Wiley and Sons
• Year: 2006
• Tongue: English
• Weight: 155 KB
• Volume: 9
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1111/j.1524-4733.2006.00083.x